Kiniksa Pharmaceuticals Ltd reports results for the quarter ended in June - Earnings Summary

Kiniksa Pharmaceuticals International

03/08/2021 15:08

* Kiniksa Pharmaceuticals Ltd  KNSA.OQ  reported a quarterly
adjusted loss of 61 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 79 cents per share.
* Revenue was $7.70 million​;  analysts expected $3.97 million. 
* Kiniksa Pharmaceuticals Ltd's reported EPS for the quarter was
a loss of 61 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kiniksa Pharmaceuticals Ltd shares had risen by 16.5% this
quarter and lost 8.1% so far this year.
* The company reported a quarterly loss of $41.56 million.
* Wall Street's median 12-month price target for Kiniksa
Pharmaceuticals Ltd is $33.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 3 at 02:08 p.m.  ​All
figures in US dollars unless otherwise stated